HeimMEHCQ • OTCMKTS
add
23andMe Holding Co.
Við síðustu lokun
1,17 $
Dagbil
1,07 $ - 1,18 $
Árabil
0,48 $ - 12,76 $
Markaðsvirði
30,85 m. USD
Meðalmagn
8,09 m.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
OTCMKTS
Í fréttum
Um
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Stofnsett
apr. 2006
Höfuðstöðvar
Vefsvæði
Starfsfólk
571